The effects of oridonin on cell growth, cell cycle, cell migration and differentiation in melanoma cells

被引:49
作者
Ren, KK
Wang, HZ
Xie, LP
Chen, DW
Liu, X
Sun, J
Nie, YC
Zhang, RQ [1 ]
机构
[1] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China
[2] Shenyang Pharmaceut Univ, Dept Pharmaceut, Shenyang 110016, Peoples R China
关键词
oridonin; melanoma; cell cycle; differentiation; migration; anti-tumor;
D O I
10.1016/j.jep.2005.07.020
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Oridonin, a diterpenoid isolated from Rabdosia rubescens (Hemsl.) Hara, is currently one of the most important traditional Chinese herbal medicines. We investigated the anti-proliferation effect of oridonin on the cultured murine melanoma cell line K1735M2. The growth inhibition activity of oridonin for K1735M2 cells occurred in a time- and dose-dependent manner (IC50 was 7.4 +/- 0.6 mu M). Further studies showed that these inhibition effects were associated with dose-dependent G2/M phase arrest and differentiation induction. Detection of morphological observation showed that oridonin could induce K1735M2 cells to produce dendrite-like structures. The results of the migration indicated that oridonin affected motility of K1735M2 cells in a dose-dependent manner. These results suggested that oridonin is a potential candidate for melanoma cancer therapy. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:176 / 180
页数:5
相关论文
共 29 条
  • [1] Metastatic melanoma: Chemotherapy
    Bajetta, E
    Del Vecchio, M
    Bernard-Marty, C
    Vitali, M
    Buzzoni, R
    Rixe, O
    Nova, P
    Aglione, S
    Taillibert, S
    Khayat, D
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (05) : 427 - 445
  • [2] CELL-CYCLE SPECIFIC CYTOTOXICITY MEDIATED BY STIZOPHYLLIN (2-ALPHA,3-BETA,12-BETA-TRIHYDROXYPREGNA-4,7,16-TRIEN-20-ONE), A NOVEL ELECTROPHILIC PREGNANE ISOLATED FROM STIZOPHYLLUM-RIPARIUM
    DUH, CY
    KINGHORN, AD
    PEZZUTO, JM
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1991, 80 (01) : 43 - 56
  • [3] Feun LG, 2000, CANCER, V88, P584, DOI 10.1002/(SICI)1097-0142(20000201)88:3<584::AID-CNCR14>3.0.CO
  • [4] 2-#
  • [5] FUJITA E, 1981, CHEM PHARM BULL, V29, P3208
  • [6] FUJITA E, 1976, CHEM PHARM BULL, V24, P2118
  • [7] ANTITUMOR ACTIVITY OF ISODON DITERPENOIDS - STRUCTURAL REQUIREMENTS FOR ACTIVITY
    FUJITA, E
    NAGAO, Y
    NODE, M
    KANEKO, K
    NAKAZAWA, S
    KURODA, H
    [J]. EXPERIENTIA, 1976, 32 (02): : 203 - 206
  • [8] FUJITA E, 1966, TETRAHEDRON LETT, P3153
  • [9] FUJITA E, 1967, J PHARM SOC JAPAN, V87, P1150
  • [10] Cytotoxic ent-kaurane diterpenoids from Isodon sculponeata
    Jiang, B
    Hou, AJ
    Li, ML
    Li, SH
    Han, QB
    Wang, SJ
    Lin, ZW
    Sun, HD
    [J]. PLANTA MEDICA, 2002, 68 (10) : 921 - 925